Interferon Omega
Dosage & Administration Guidelines
| Species | Route | Dose | Frequency | Duration & Clinical Notes |
|---|---|---|---|---|
| Dog | SC | 1-2.5 million IU/kg | q24h | Duration: 3-5 days for parvovirus; up to 2 weeks for chronic infections Notes: For parvovirus, administer early in the course of disease. For chronic viral infections, longer courses may be needed. |
| Cat | SC | 1-5 million IU/kg | q24h | Duration: 5 days for acute infections; for FeLV/FIV, may be used 3 times weekly for several months Notes: For FeLV/FIV, a common protocol is 1 million IU/kg SC three times a week for 4-6 weeks, then reassess. |
| Horse | IV | 0.5-1 million IU/kg | q24h | Duration: 3-5 days Notes: Use with caution in horses; monitor for pyrexia and flu-like signs. |
Clinical Indications & Species Uses
- Immunomodulation in viral infections
- Adjunct therapy in viral diseases
- Treatment of canine parvovirus infection
- Adjunct therapy for canine distemper
- Management of chronic viral infections (e.g., canine herpesvirus)
- Treatment of feline leukemia virus (FeLV) infection
- Treatment of feline immunodeficiency virus (FIV) infection
- Adjunct therapy for feline infectious peritonitis (FIP)
- Treatment of feline herpesvirus (FHV-1) infections
- Treatment of feline calicivirus infections
- Treatment of equine herpesvirus infections
- Immunomodulatory therapy for viral respiratory infections
Pharmacology & Mechanism of Action
Drug Class: Immunomodulator / Cytokine | Pharmacological Group: Interferon
Mechanism of Action: Interferon omega is a type I interferon that binds to the type I interferon receptor (IFNAR) on cell surfaces, activating the JAK-STAT signaling pathway. This leads to the transcription of interferon-stimulated genes (ISGs) that produce antiviral, antiproliferative, and immunomodulatory proteins. It enhances the innate immune response by increasing the activity of natural killer cells, macrophages, and cytotoxic T lymphocytes, and by upregulating major histocompatibility complex (MHC) class I expression. It also inhibits viral replication directly by inducing enzymes such as 2',5'-oligoadenylate synthetase and protein kinase R.
Pharmacodynamics: Interferon omega exhibits broad-spectrum antiviral activity against various DNA and RNA viruses, including feline herpesvirus, feline calicivirus, and canine parvovirus. It also modulates the immune response, reducing inflammation and promoting viral clearance. In veterinary medicine, it is used to stimulate the immune system in viral infections and to improve clinical outcomes in diseases like feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Its effects are dose-dependent, with higher doses providing more pronounced antiviral and immunomodulatory actions.
⚡ Pharmacokinetics Summary
Available Formulations & Strengths
Contraindications & Clinical Warnings
- Hypersensitivity to interferons or any component of the formulation
- Severe hepatic or renal impairment (use with caution)
- Pregnancy (unless benefits outweigh risks; limited safety data)
- Lactating animals (use with caution; may be excreted in milk)
- Use with caution in animals with pre-existing autoimmune diseases
- May cause transient fever, lethargy, and anorexia; supportive care may be needed
- Monitor complete blood count and liver enzymes during prolonged therapy
- Do not administer with live vaccines; may interfere with vaccine response
- Use in food animals is not recommended; withdrawal times not established
Adverse Effects & Reactions
Common:
- Fever
- Lethargy
- Anorexia
- Injection site reactions (pain, swelling)
- Transient leukopenia
Serious / Severe:
- Severe allergic reactions (anaphylaxis)
- Bone marrow suppression (with prolonged high doses)
- Hepatotoxicity
- Renal toxicity
Rare:
- Seizures
- Cardiovascular effects (hypotension)
- Autoimmune hemolytic anemia
Key Drug Interactions
| Interacting Drug / Class | Clinical Effect & Mechanism | Severity |
|---|---|---|
| Live vaccines | Interferon may reduce the efficacy of live vaccines; avoid concurrent administration. | Moderate |
| Immunosuppressive agents (e.g., corticosteroids) | May antagonize the immunostimulatory effects of interferon; avoid concurrent use. | Moderate |
| Nephrotoxic drugs (e.g., aminoglycosides) | Increased risk of renal toxicity; monitor renal function. | High |
| Hepatotoxic drugs (e.g., azole antifungals) | Increased risk of hepatotoxicity; monitor liver enzymes. | High |
Overdose & Toxicity Management
Signs of Toxicity:
- Severe fever
- Vomiting
- Diarrhea
- Lethargy
- Bone marrow suppression
- Hepatic and renal dysfunction
Emergency Treatment Protocol: There is no specific antidote. Treatment is symptomatic and supportive. Discontinue the drug, provide fluid therapy, and manage fever with antipyretics. Monitor organ function and hematological parameters. In severe cases, consider hospitalization and intensive care.
Food Animal Withdrawal Times
Not approved for use in food animals; withdrawal times not established. Do not use in animals intended for food production.
Storage, Handling & Regulatory Information
Storage Temperature: Store at 2-8°C (refrigerate). Do not freeze.
Light Sensitivity: Light-sensitive — protect from direct exposure.
Handling & Special Conditions: Protect from light. Reconstituted solution should be used immediately or stored at 2-8°C for up to 24 hours. Discard any unused portion.
Dispensing Status: Prescription Required (Rx Only)
Approval Status: Approved for use in cats and dogs in some countries (e.g., Europe, Japan). Not FDA-approved in the US; may be used extra-label.
Extra-Label (Off-Label) Use: In the US, extra-label use of interferon omega is permitted under AMDUCA for non-food animals. For food animals, extra-label use is prohibited due to lack of withdrawal times. In the EU, it is approved for use in cats and dogs.
Clinical Pearls & Practice Notes
References & Literature
- 📚 Plumb's Veterinary Drug Handbook
- 📚 Papich Veterinary Pharmacology and Therapeutics
- 📚 Compendium of Veterinary Products (CVP)